Verity Asset Management, Inc. Madrigal Pharmaceuticals, Inc. Transaction History

Verity Asset Management, Inc.

$266 Billion
Q3 2024

A detailed history of Verity Asset Management, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Verity Asset Management, Inc. holds 1,466 shares of MDGL stock, worth $452,173. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,466

Previous 1,365 7.4%

Holding current value

$452,173

Previous $382 Million 18.65%

% of portfolio

0.12%

Previous 0.15%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$212.22 - $292.96 $21,434 - $29,588	101 Added 7.4%	1,466 $311 Million
Q2 2024 Aug 08, 2024	SELL	$193.33 - $291.99 $40,405 - $61,025	-209 Reduced 13.28%	1,365 $382 Million
Q1 2024 May 28, 2024	SELL	$171.37 - $283.23 $191,077 - $315,801	-1,115 Reduced 41.47%	1,574 $420 Million
Q4 2023 Feb 08, 2024	BUY	$120.4 - $237.13 $240 - $474	2 Added 0.07%	2,689 $622 Million
Q3 2023 Nov 22, 2023	BUY	$146.04 - $225.78 $105,294 - $162,787	721 Added 36.67%	2,687 $392 Million
Q2 2023 Aug 15, 2023	BUY	$203.88 - $312.0 $100,308 - $153,504	492 Added 33.38%	1,966 $454 Million
Q1 2023 May 24, 2023	BUY	$231.06 - $307.08 $104,439 - $138,800	452 Added 44.23%	1,474 $357 Million
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $165,243 - $839,208	-2,830 Reduced 73.47%	1,022 $297 Million
Q3 2022 Nov 15, 2022	BUY	$60.57 - $79.51 $63,659 - $83,565	1,051 Added 37.52%	3,852 $250 Million
Q1 2022 May 23, 2022	SELL	$55.89 - $101.89 $219,368 - $399,918	-3,925 Reduced 58.36%	2,801 $275,000
Q1 2022 May 12, 2022	BUY	$55.89 - $101.89 $227,472 - $414,692	4,070 Added 153.24%	6,726 $275,000
Q4 2021 Feb 08, 2022	SELL	$72.34 - $95.09 $23,148 - $30,428	-320 Reduced 10.75%	2,656 $225,000
Q3 2021 Nov 10, 2021	BUY	$78.35 - $105.02 $48,420 - $64,902	618 Added 26.21%	2,976 $237,000
Q2 2021 Aug 04, 2021	BUY	$97.2 - $137.59 $4,762 - $6,741	49 Added 2.12%	2,358 $230,000
Q1 2021 May 10, 2021	BUY	$108.54 - $125.2 $50,362 - $58,092	464 Added 25.15%	2,309 $270,000
Q4 2020 Feb 05, 2021	BUY	$110.06 - $133.7 $203,060 - $246,676	1,845 New	1,845 $205,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verity Asset Management, Inc. with notifications on news.

Account

Verity Asset Management, Inc. Madrigal Pharmaceuticals, Inc. Transaction History